Windtree Therapeutics Enters Material Agreement
Ticker: WINTW · Form: 8-K · Filed: Apr 30, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
TL;DR
Windtree Therapeutics signed a new deal, filed financials, and reported equity sales.
AI Summary
On April 29, 2025, Windtree Therapeutics, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The filing details are associated with accession number 0001437749-25-013630.
Why It Matters
This 8-K filing indicates a significant new agreement for Windtree Therapeutics, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — Material definitive agreements and unregistered equity sales can introduce financial and operational risks for a company.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- April 29, 2025 (date) — Date of earliest event reported
- 0001437749-25-013630 (accession_number) — SEC filing accession number
FAQ
What type of material definitive agreement did Windtree Therapeutics enter into?
The filing states that Windtree Therapeutics, Inc. entered into a material definitive agreement on April 29, 2025, but the specific details of the agreement are not provided in this excerpt.
What is the accession number for this 8-K filing?
The accession number for this 8-K filing is 0001437749-25-013630.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on April 29, 2025.
What other items are reported in this 8-K filing besides the material definitive agreement?
This 8-K filing also reports on unregistered sales of equity securities and includes financial statements and exhibits.
What is the standard industrial classification for Windtree Therapeutics, Inc.?
The standard industrial classification for Windtree Therapeutics, Inc. is Biological Products (No Diagnostic Substances) [2836].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).